Literature DB >> 6821618

Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia.

J Neuberger, A E Gimson, M Davis, R Williams.   

Abstract

The aetiology of massive liver-cell necrosis which developed in 16 patients following halothane anaesthesia was investigated by means of new serological techniques. In eight patients a specific halothane-related antibody was found, indicating that these patients were sensitized to halothane-altered liver-cell membrane components. In four patients, hepatitis A viral infection was responsible and among the remainder one was receiving anti-tuberculous drugs and one had received a blood transfusion, thus raising the possibility of a non-A non-B viral infection. There were no biochemical or histological differences between patients in the three groups.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821618     DOI: 10.1093/bja/55.1.15

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

Review 1.  Halothane anaesthesia and liver damage.

Authors:  J Neuberger; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

Review 2.  Halothane and hepatitis. Incidence, predisposing factors and exposure guidelines.

Authors:  J M Neuberger
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

3.  Differential diagnosis of postoperative liver failure in a 12-year-old child.

Authors:  R Hausmann; B Schmidt; B Schellmann; P Betz
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

4.  Characterization of a halothane-induced humoral immune response in rabbits.

Authors:  A H Callis; S D Brooks; T P Roth; A J Gandolfi; B R Brown
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

5.  Chronology of halothane-induced antigen expression in halothane-exposed rabbits.

Authors:  T P Roth; A K Hubbard; A J Gandolfi; B R Brown
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.